Vista Pharmaceuticals share news, announcements and annual reports
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 2 Nov 2026. Previous close ₹6.21.
2 Nov: open ₹6.21, high ₹6.50, low ₹6.02
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,053
Vista Pharmaceuticals share news and announcements
532 announcements, routine notices left out, newest first. Page 8 of 11.
Mar 2018
Feb 2018
20 Feb · Board Meeting To Be Held On 24/02/2018
10 Feb · Announcement under Regulation 30 (LODR)-Updates
Jan 2018
21 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....19 Jan · Statement Of Investor Complaints For The Quarter Ended 31.12.2017
9 Jan · Board meeting
Dec 2017
7 Dec · Board meeting
Nov 2017
28 Nov · Board meeting
25 Nov · Board Meeting Rescheduled
20 Nov · Board meeting
Oct 2017
28 Oct · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
28 Oct · Compliance Certificate For The Period Ended 30.09.2017
24 Oct · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....24 Oct · Results
24 Oct · Meeting
17 Oct · Updates
10 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....6 Oct · Meeting
1 Oct · Meeting
Sep 2017
30 Sep · Board meeting
27 Sep · Board Meeting On 30.09.2017
25 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....25 Sep · Meeting
21 Sep · Updates
7 Sep · Updates
Aug 2017
12 Aug · Board Meeting Postponed
8 Aug · Board Meeting To Be Held On 14Th August, 2017.
5 Aug · Shareholding for the Period Ended July 28, 2017
Shareholding Pattern for the Period Ended July 28, 2017. For more details, kindly Click ....
Jul 2017